Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy.
"I have got something positive out of this situation": psychological benefits of caregiving in relatives of young people with muscular dystrophy.
Muscle MR Imaging in Tubular Aggregate Myopathy.
6 minute walk test in Duchenne MD patients with different mutations: 12 month changes.
Pilot trial of clenbuterol in spinal and bulbar muscular atrophy.
Correction: 24 Month Longitudinal Data in Ambulant Boys with Duchenne Muscular Dystrophy.
24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy.
Cardiomyopathy in patients with POMT1-related congenital and limb-girdle muscular dystrophy.
Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy.
Clinical and molecular characterization of limb-girdle muscular dystrophy due to LAMA2 mutations.
Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study.
Cognitive profile and MRI findings in limb-girdle muscular dystrophy 2I.
SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy.
North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy.
Reliability of the North Star Ambulatory Assessment in a multicentric setting.
Mitochondrial disorders of the nuclear genome.
TGFBR2 but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscle
Parkinson-like features in ALS with predominant upper motor neuron involvement